Notes to Consolidated Financial Statements (Unaudited)
March
31
, 201
6
(Dollars in T
housands)
(1)
Basis of Presentation and Consolidation
As used herein, the terms “Company,” “Landauer,” “we,” “us,” and “our” refer collectively to Landauer, Inc. and its subsidiaries through which
its
various businesses are conducted.
The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and the instructions to Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.
The consolidated financial statements include the accounts of the Company, its subsidiaries and variable interest entities in which the Company has a controlling financial interest. All intercompany balances and transactions have been eliminated in consolidation. Entities in which the Company does not have a controlling financial interest, but is considered to have significant influence, are accounted for on the equity method.
The preparation of the interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the interim consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
We believe that we have included all normal recurring adjustments necessary for a fair presentation of the results for the interim period. Operating results for the
three
and six month
period
s
ended
March
31
, 201
6
are not necessarily indicative of the results that may be expected for the fiscal year ending September 30, 201
6
.
These
consolidated
financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 201
5
(the “Form 10-K”) and other financial information filed with the Securities and Exchange Commission (the “SEC”). The September 30, 201
5
balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.
The accounting policies followed by the Company are set forth in the Form 10-K, and there have been no changes to the accounting policies for the
six
-
month period ended
March
31
, 201
6
.
(2)
Recent Accounting Pronouncements
Accounting Standards Not Yet Adopted
In May 2014, the
Financial Accounting Standards Board (“FASB”)
issued new guidance for recognizing revenue from contracts with customers, which provides a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and will supersede most current revenue recognition guidance. In
July
2015, the FASB
deferred
the effective date of the new revenue standard
by one year
. Public companies would
now
be required to adopt the new guidance for fiscal years
,
and interim periods within those
fiscal
years
,
beginning after December 15, 2017
.
The FASB decided to allow earlier
adoption
of the new revenue standard, but not earlier than the original effective date
.
This guidance is effective for the Company in the first quarter of fiscal 2019.
The Company is currently evaluating the impact that adoption of this guidance will have on its
results of operations, financial position
and
liquidity
.
In June 2014, the FASB issued new guidance on accounting for share-based payments requiring a specific performance target to be achieved in order for employees to become eligible to vest in the awards when that performance target may be achieved after the requisite service period for the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period for which the requisite service has already been rendered. This guidance is effective for the Company in the first quarter of fiscal 2017. Early adoption is permitted. The Company is currently evaluating the impact
that adoption of
this guidance will have on its results of operations, financial position and liquidity.
In August 2014, the FASB issued new guidance on determining when and how to disclose going-concern uncertainties in the financial statements. The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of doubt about the entity’s ability to continue as a going concern. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. This guidance will be effective for the Company in the first quarter of fiscal 2017, with early adoption permitted. The Company does not expect the adoption of this guidance will have a material impact on its results of operations, financial position and liquidity.
In January 2015, the FASB issued new guidance on accounting for unusual and infrequently occurring items, which eliminates the concept of extraordinary items. An unusual and infrequently occurring item will no longer be classified as an extraordinary item and segregated from ordinary operations in the income statement, but will be shown as a component of income from continuing operations or separately disclosed in notes to the financial statements. This guidance is effective for the Company in the first quarter of fiscal 2017, with early adoption permitted. The Company does not expect the adoption of this guidance will have a material impact on its results of operations, financial position and liquidity.
In February 2015, the FASB issued amended guidance on the model used to evaluate whether certain legal entities should be consolidated. This guidance is effective for the Company in the first quarter of fiscal 2017. Early adoption is permitted. The Company is currently evaluating the impact this guidance will have on its results of operations, financial position and liquidity.
In April 2015, the FASB issued new guidance on the presentation of debt issuance costs. This update requires a company to present debt issuance costs related to a recognized debt liability in the balance sheet as a direct deduction from the carrying amount of the related debt liability, consistent with the presentation of debt discounts. Currently, debt issuance costs are presented as a deferred asset. The recognition and measurement requirements will not change as a result of this guidance. The update requires retrospective application and represents a change in accounting principle. This guidance is effective for the Company in the first quarter of fiscal 2017, with early adoption permitted. The Company does not expect the adoption of this guidance will have a material impact on its results of operations, financial position and liquidity.
In July 2015, the FASB issued new guidance on simplifying the measurement of inventory. This update requires a company to measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. This guidance is effective for the Company in the first quarter of fiscal 2018, and should be applied prospectively with early adoption permitted. The Company is currently evaluating the impact this guidance will have on its results of operations, financial position and liquidity.
In September 2015, the FASB issued new guidance on business combination provisional adjustments during the measurement period. The new standard requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined and sets forth new disclosure requirements related to the adjustments. This guidance is effective for the Company in the first quarter of fiscal 2017, with early adoption permitted. The Company is currently evaluating the impact this guidance will have on its results of operations, financial position and liquidity.
In November 2015, the FASB issued new guidance on the presentation of deferred income taxes. This update requires a company to present deferred tax liabilities and assets as noncurrent in a classified statement of financial position rather than the current requirement to separate deferred income tax liabilities and assets into current and noncurrent amounts. This guidance is effective for the Company in the first quarter of fiscal 2018, with early adoption permitted. The Company does not expect the adoption of this guidance will have a material impact on its results of operations, financial position and liquidity.
In January 2016, the FASB issued guidance on the recognition and measurement of financial instruments.
This guidance retains the current accounting for classifying and measuring investments in debt securities and loans, but requires equity investments to be measured at fair value with subsequent changes recognized in net income, except for those accounted for under the equity method or requiring consolidation.
The guidance also changes the accounting for investments without a readily determinable fair value and that do not qualify for the practical expedient to estimate fair value.
A policy election can be made for these investments whereby estimated fair value may be measured at cost and adjusted in subsequent periods for any impairment or changes in observable prices of identical or similar investments.
This guidance is effective for the Company in the first quarter of fiscal 2019. The Company is currently evaluating the impact that adoption of this guidance will have on its results of operations, financial position and liquidity.
In February 2016, the FASB issued guidance on the accounting treatment for leases. This guidance will require all leases with durations greater than twelve months to be recognized on the balance sheet of the lessee. For income statement purposes, the FASB retained a dual model, requiring leases to be classified as either operating or finance. Classification will be based on criteria that are largely similar to those applied in current lease accounting, but without explicit bright lines. This guidance is effective for the Company in the first quarter of fiscal 2020, although early adoption is permitted. The Company is currently evaluating the impact that adoption of this guidance will have on its results of operations, financial position and liquidity.
In March 2016, the FASB issued guidance on the accounting for equity method investments. This standard eliminates the requirement that when an existing cost method investment qualifies for the use of the equity method, an investor must restate its historical financial statements, as if the equity method had been used during all previous periods. Under the new guidance, at the point an investment qualifies for the equity method, any unrealized gain or loss in accumulated other comprehensive income/(loss) (“AOCI”) will be recognized through earnings. The standard is effective for the Company in the first quarter of fiscal 2018, although early adoption is permitted. The Company is currently evaluating the impact that adoption of this guidance will have on its results of operations, financial position and liquidity.
In March 2016, the FASB issued new guidance to improve the accounting for share-based payments. This standard makes several modifications to Topic 718 related to the accounting for forfeitures, employer tax withholding on share-based compensation and the financial statement presentation of excess tax benefits or deficiencies. The guidance also clarifies the statement of cash flows presentation for certain components of share-based awards. The standard is effective for the Company in the first quarter of fiscal 2018, although early adoption is permitted. The Company is currently evaluating the impact that adoption of this guidance will have on its results of operations, financial position and liquidity.
No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on the Consolidated Financial Statements.
(3)
Fair Value Measurements
The Company
estimate
s
the
fair value
of
assets and liabilities
in accordance with
the framework established
by
the
authoritative guidance for fair value measurements
.
The framework is based on the inputs used in valuation, gives the highest priority to quoted prices in active markets and requires that observable inputs be used in
the valuations when available.
The disclosure of fair value estimates in the fair value accounting guidance hierarchy is based on whether the significant inputs int
o the valuation are observable.
In determining the level of the hierarchy in which the estimate is disclosed, the highest priority is given to unadjusted quoted prices in active markets and the lowest priority to unobservable inputs that reflect the Company’s
significant market assumptions.
The level in the fair value hierarchy within which the fair value measurement is reported is based on the lowest level input that is significant to t
he measurement in its entirety.
The three levels of the hierarchy are as follows:
|
·
|
|
Level 1
– Unadjusted
quoted prices in active markets for identical assets
or
liabilities
t
hat the Company has the ability to access
as of the reporting date
.
|
|
·
|
|
Level 2
– I
nputs other than quoted prices
included within Level 1 that are directly
observable for the asset or liability
or indirectly observable through corroboration with observable market data.
|
|
·
|
|
Level 3
– Unobservable
inputs
for the asset or liability used to measure fair value that
reflect
the Company’s
own assumptions
about the assumptions
market participants would use in pricing the asset or liability.
|
Financial assets measured at fair value on a recurring basis are summarized below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements at March 31, 2016
|
(Dollars in Thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
Asset Category
|
|
|
|
|
|
|
|
|
Cash equivalents
|
$
|
500
|
|
$
|
-
|
|
$
|
-
|
Mutual funds
|
|
3,710
|
|
|
-
|
|
|
-
|
Available-for-sale securities
|
|
-
|
|
|
2,341
|
|
|
-
|
Total financial assets at fair value
|
$
|
4,210
|
|
$
|
2,341
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements at September 30, 2015
|
(Dollars in Thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
Asset Category
|
|
|
|
|
|
|
|
|
Cash equivalents
|
$
|
272
|
|
$
|
-
|
|
$
|
-
|
Mutual funds
|
|
3,237
|
|
|
-
|
|
|
-
|
Available-for-sale securities
|
|
-
|
|
|
1,763
|
|
|
-
|
Total financial assets at fair value
|
$
|
3,509
|
|
$
|
1,763
|
|
$
|
-
|
Following is a description of each category in the fair value hierarchy and the financial assets and liabilities of the Company that were included in each category at
March
31
, 201
6
and September 30, 201
5
, measured on a recurring basis.
The Level 1 financial assets were comprised of investments in trading securities, which are reported in other long-term assets. The investments are held in a Rabbi trust for benefits under the Company’s deferred compensation plan. Under the plan, participants designate investment options to serve as the basis for measurement of the notional value of their accounts. The investments include a money market fund and mutual funds that are publicly traded. The fair values of the shares or underlying securities of these funds are based on quoted market prices.
The Level 2 financial assets are long-term investments consisting primarily of fixed income mutual funds, classified as available-for-sale securities. These
investments
are reported in other long-term assets. The investments in fixed income mutual funds are valued based on the net asset value of the underlying securities as provided by the investment account manager. The investments are not restricted or subject to a lockup and may be redeemed on demand. Notice within a certain period of time prior to redemption is not required.
The Company’s long
-
term debt is classified as Level 2. The carrying amount of the Company’s long-term debt
is the
approximated fair value
,
as the stated interest rates were variable in relation to prevailing market rates.
The Company recorded a liability for contingent consideration during the second quarter of fiscal 2014 related to the acquisition of ilumark GmbH and the launch of its new medical products. The liability was recorded at fair value, which was determined using a discounted cash flow model based on assumptions and projections relevant to revenues. A discount rate of
11%
was used and payments are projected to occur in fiscal 2016 and 2017.
The contingent consideration liability is classified as Level 3.
The Company had
no
material assets or liabilities that were measured at fair value on a non-recurring basis during the
six
months ended
March
31
, 201
6
or
fiscal
year
ended
September
3
0
, 201
5
.
There were
no
transfers between fair value hierarchy levels during the
se
period
s
.
(4)
Income per Common Share
Basic net
income
per share was computed by dividing net
income
available to common stockholders for the period by the weighted average number of shares of common stock outstanding during the period. Diluted net
income
per share was computed by dividing net
income
available to common stockholders for the period by the weighted average number of shares of common stock that would have been outstanding assuming dilution from stock-based compensation awards during the period.
The following table sets forth the computation of net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31,
|
|
Six Months Ended
March 31,
|
(Dollars in Thousands, Except per Share)
|
2016
|
|
2015
|
|
2016
|
|
2015
|
Basic Net Income per Share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributed to Landauer, Inc.
|
|
$
|
4,279
|
|
$
|
3,547
|
|
$
|
7,922
|
|
$
|
7,924
|
Less: Income allocated to unvested restricted stock
|
|
|
21
|
|
|
18
|
|
|
39
|
|
|
47
|
Net income available to common stockholders
|
|
$
|
4,258
|
|
$
|
3,529
|
|
$
|
7,883
|
|
$
|
7,877
|
Basic weighted average shares outstanding
|
|
|
9,518
|
|
|
9,493
|
|
|
9,483
|
|
|
9,464
|
Net income per share - Basic
|
|
$
|
0.45
|
|
$
|
0.37
|
|
$
|
0.83
|
|
$
|
0.83
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted Net Income per Share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributed to Landauer, Inc.
|
|
$
|
4,279
|
|
$
|
3,547
|
|
$
|
7,922
|
|
$
|
7,924
|
Less: Income allocated to unvested restricted stock
|
|
|
21
|
|
|
18
|
|
|
39
|
|
|
47
|
Net income available to common stockholders
|
|
$
|
4,258
|
|
$
|
3,529
|
|
$
|
7,883
|
|
$
|
7,877
|
Basic weighted average shares outstanding
|
|
|
9,518
|
|
|
9,493
|
|
|
9,483
|
|
|
9,464
|
Effect of dilutive securities
|
|
|
32
|
|
|
27
|
|
|
33
|
|
|
28
|
Diluted weighted averages shares outstanding
|
|
|
9,550
|
|
|
9,520
|
|
|
9,516
|
|
|
9,492
|
Net income per share - Diluted
|
|
$
|
0.45
|
|
$
|
0.37
|
|
$
|
0.83
|
|
$
|
0.83
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid per share
|
|
$
|
0.275
|
|
$
|
0.275
|
|
$
|
0.55
|
|
$
|
0.825
|
On
February 18
, 201
6
, the Company declared a regular quarterly cash dividend in the amount of
$0.275
per share for the
second
quarter of fiscal 201
6
. The dividends were paid on
April 4
, 2016
to shareholders of record as of
March
18, 201
6
.
(5)
Employee Benefit Plans
The components of net periodic benefit cost for pension and other benefits were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
Three Months Ended
March 31,
|
|
Six Months Ended
March 31,
|
(Dollars in Thousands)
|
2016
|
|
2015
|
|
2016
|
|
2015
|
Interest cost
|
$
|
393
|
|
$
|
364
|
|
$
|
785
|
|
$
|
728
|
Expected return on plan assets
|
|
(374)
|
|
|
(396)
|
|
|
(747)
|
|
|
(792)
|
Amortization of net loss
|
|
140
|
|
|
84
|
|
|
281
|
|
|
168
|
Net periodic benefit cost
|
$
|
159
|
|
$
|
52
|
|
$
|
319
|
|
$
|
104
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Benefits
|
Three Months Ended
March 31,
|
|
Six Months Ended
March 31,
|
(Dollars in Thousands)
|
2016
|
|
2015
|
|
2016
|
|
2015
|
Service cost
|
$
|
15
|
|
$
|
12
|
|
$
|
30
|
|
$
|
25
|
Interest cost
|
|
9
|
|
|
8
|
|
|
19
|
|
|
16
|
Amortization of net gain
|
|
(4)
|
|
|
(12)
|
|
|
(8)
|
|
|
(24)
|
Net periodic benefit cost
|
$
|
20
|
|
$
|
8
|
|
$
|
41
|
|
$
|
17
|
The Company, under the IRS minimum funding standards, has
no
required contributions to make to its defined benefit pension plan during fiscal 201
6
.
The Company
sponsors a
401(k)
r
etirement
s
avings
p
lan
covering substantially all
of the
U.S. full-time
employees
in the Company’s Radiation Measurement segment
as well as substantially all of the
employees in the
Company’s Medical Physics and Medical Products segments
, which provide
s
for
certain
employer matching contributions
. The Company also maintains
a supplemental defined contribution plan for certain executives, which
allows participating executives to make voluntary deferrals and
provides for employer contributions at the discretion of the Company. Amounts expensed for Company contributions under these plans during the three months ended
March
31
, 201
6
and 201
5
were
$
4
99
and
$
442
, respectively.
Amounts expensed for Company contributions under these plans during the
six
months ended
March 31
, 201
6
and 201
5
were
$
918
and
$849
, respectively.
(6)
Goodwill and Intangible Assets
Changes in the carrying amount of goodwill
,
by reportable segment
,
for the
six
months ended
March
31
, 201
6
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in Thousands)
|
|
Radiation Measurement
|
|
Medical Physics
|
|
Medical Products
|
|
Total
|
Balance as of September 30, 2015
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill
|
|
$
|
11,002
|
|
$
|
22,611
|
|
$
|
65,527
|
|
$
|
99,140
|
Accumulated impairment losses
|
|
|
-
|
|
|
-
|
|
|
(64,068)
|
|
|
(64,068)
|
Balance as of September 30, 2015
|
|
$
|
11,002
|
|
$
|
22,611
|
|
$
|
1,459
|
|
$
|
35,072
|
Effects of foreign currency
|
|
|
159
|
|
|
-
|
|
|
9
|
|
|
168
|
Balance as of March 31, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill
|
|
$
|
11,161
|
|
$
|
22,611
|
|
$
|
65,536
|
|
$
|
99,308
|
Accumulated impairment losses
|
|
|
-
|
|
|
-
|
|
|
(64,068)
|
|
|
(64,068)
|
Balance as of March 31, 2016
|
|
$
|
11,161
|
|
$
|
22,611
|
|
$
|
1,468
|
|
$
|
35,240
|
Intangible assets consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2016
|
(Dollars in Thousands)
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net Carrying Amount
|
|
Accumulated Intangibles Impairment Charge
|
Customer lists
|
|
$
|
43,198
|
|
$
|
34,496
|
|
$
|
8,702
|
|
$
|
18,657
|
Trademarks and tradenames
|
|
|
2,183
|
|
|
2,051
|
|
|
132
|
|
|
1,498
|
Licenses and patents
|
|
|
6,296
|
|
|
2,501
|
|
|
3,795
|
|
|
665
|
Other intangibles
|
|
|
577
|
|
|
557
|
|
|
20
|
|
|
-
|
Intangible assets
|
|
$
|
52,254
|
|
$
|
39,605
|
|
$
|
12,649
|
|
$
|
20,820
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2015
|
(Dollars in Thousands)
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net Carrying Amount
|
|
Accumulated Intangibles Impairment Charge
|
Customer lists
|
|
$
|
43,131
|
|
$
|
33,716
|
|
$
|
9,415
|
|
$
|
18,657
|
Trademarks and tradenames
|
|
|
2,181
|
|
|
2,051
|
|
|
130
|
|
|
1,498
|
Licenses and patents
|
|
|
5,825
|
|
|
2,338
|
|
|
3,487
|
|
|
665
|
Other intangibles
|
|
|
577
|
|
|
557
|
|
|
20
|
|
|
-
|
Intangible assets
|
|
$
|
51,714
|
|
$
|
38,662
|
|
$
|
13,052
|
|
$
|
20,820
|
Identifiable intangible assets with finite lives are amortized over their estimated useful lives. Intangible asset amortization expense was $
568
and $
1,123
for the three
and six
months ended
March
31
, 201
6
, respectively,
and
was
$558
and
$1,121
for the three
and six months ended March 31
,
201
5
, respectively
.
(7)
Accumulated Other Comprehensive Loss
Accumulated elements of other comprehensive loss, net of tax, are included in the stockholders’ equity section of the condensed consolidated balance sheets. Changes in each component for the
six
months ended
March
31
are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in Thousands)
|
Foreign Currency Translation Adjustments
|
|
Unrealized Gains and Losses on Available-for-Sale Securities
|
|
Pension and Postretirement Plans
|
|
Comprehensive (Loss) Income
|
Balance at September 30, 2015
|
$
|
(5,468)
|
|
$
|
259
|
|
$
|
(8,532)
|
|
$
|
(13,741)
|
Other comprehensive (loss) income before reclassifications
|
|
663
|
|
|
97
|
|
|
-
|
|
|
760
|
Amounts reclassified from accumulated other comprehensive (loss) income
|
|
-
|
|
|
(89)
|
|
|
172
|
|
|
83
|
Net current period other comprehensive (loss) income
|
|
663
|
|
|
8
|
|
|
172
|
|
|
843
|
Balance at March 31, 2016
|
$
|
(4,805)
|
|
$
|
267
|
|
$
|
(8,360)
|
|
$
|
(12,898)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in Thousands)
|
Foreign Currency Translation Adjustments
|
|
Unrealized Gains and Losses on Available-for-Sale Securities
|
|
Pension and Postretirement Plans
|
|
Comprehensive (Loss) Income
|
Balance at September 30, 2014
|
$
|
(2,493)
|
|
$
|
166
|
|
$
|
(7,821)
|
|
$
|
(10,148)
|
Other comprehensive (loss) income before reclassifications
|
|
(3,698)
|
|
|
101
|
|
|
-
|
|
|
(3,597)
|
Amounts reclassified from accumulated other comprehensive (loss) income
|
|
-
|
|
|
(99)
|
|
|
91
|
|
|
(8)
|
Net current period other comprehensive (loss) income
|
|
(3,698)
|
|
|
2
|
|
|
91
|
|
|
(3,605)
|
Balance at March 31, 2015
|
$
|
(6,191)
|
|
$
|
168
|
|
$
|
(7,730)
|
|
$
|
(13,753)
|
The tables below present the impact on net income of significant amounts reclassified out of each component of accumulated other comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension and Postretirement Plans
(1)
|
Three Months Ended
March 31,
|
|
Six Months Ended
March 31,
|
(Dollars in Thousands)
|
2016
|
|
2015
|
|
2016
|
|
2015
|
Amortization of net loss
|
$
|
204
|
|
$
|
72
|
|
$
|
273
|
|
$
|
144
|
Total before tax
|
|
204
|
|
|
72
|
|
|
273
|
|
|
144
|
Provision for income taxes
|
|
76
|
|
|
53
|
|
|
101
|
|
|
53
|
Total net of tax
|
$
|
128
|
|
$
|
19
|
|
$
|
172
|
|
$
|
91
|
(1)
These accumulated other comprehensive loss components are included in the computation of net periodic benefit costs (refer to Note 5 of the Notes to Consolidated Financial Statements for additional details regarding employee benefit plans).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized Gains and Losses on Available-for-Sale Securities
|
Three Months Ended
March 31,
|
|
Six Months Ended
March 31,
|
(Dollars in Thousands)
|
2016
|
|
2015
|
|
2016
|
|
2015
|
Realized gains on available-for-sale securities into earnings
(1)
|
$
|
-
|
|
$
|
(7)
|
|
$
|
(105)
|
|
$
|
(99)
|
Total before tax
|
|
-
|
|
|
(7)
|
|
|
(105)
|
|
|
(99)
|
Provision for income taxes
(2)
|
|
-
|
|
|
-
|
|
|
(16)
|
|
|
-
|
Total net of tax
|
$
|
-
|
|
$
|
(7)
|
|
$
|
(89)
|
|
$
|
(99)
|
(1)
This amount is reported in Interest
e
xpense, net on the Consolidated Statements of Operations
(2)
This amount is reported in Income
t
ax
e
xpense
on the Consolidated Statements of Operations
(8)
Income Taxes
The effective tax rate
s
for the
three months ended
March
31
,
201
6
and 201
5
were
31.1
%
and
24.3
%
,
respectively.
The
in
crease in the effective tax rate was primarily
due
to the mix of earnings b
etween
jurisdiction
s
with differing tax rates.
The effective tax rates for the six months ended March 31, 2016 and 2015 were
31.0
%
and
25.4%
, respectively.
The increase in the effective tax rate was primarily due to the mix of earnings between jurisdictions with differing tax rates
, estimated foreign tax credit, and ratio of permanent items versus a lower overall forecasted pretax
.
The Company believes it is reasonably possible that
$
64
5
thousand
of unrecognized tax benefits will be realized in
fiscal
year
2016
.
(9)
Segment Information
The Company is organized into
three
reportable business segments:
Radiation Measurement, Medical Physics and Medical Products
.
These segments reflect the manner in which the Company’s businesses are currently managed and represent an aggregation of services
and products
based on type of customer
and
how the business
es are
marketed.
For more information regarding the
nature of
the
Company’s
services and products
, see
N
ote 1
6
of
the N
otes to
C
onsolidated
F
inancial
S
tatements in the
Form 10-K
.
The following tables summarize financial information for each reportable segment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31,
|
|
Six Months Ended
March 31,
|
(Unaudited, Dollars in Thousands)
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
Revenues by segment:
|
|
|
|
|
|
|
|
|
|
|
|
|
Radiation Measurement
|
|
$
|
25,520
|
|
$
|
27,246
|
|
$
|
50,224
|
|
$
|
53,737
|
Medical Physics
|
|
|
10,033
|
|
|
8,561
|
|
|
19,386
|
|
|
17,045
|
Medical Products
|
|
|
2,529
|
|
|
2,332
|
|
|
5,002
|
|
|
4,904
|
Consolidated revenues
|
|
$
|
38,082
|
|
$
|
38,139
|
|
$
|
74,612
|
|
$
|
75,686
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31,
|
|
Six Months Ended
March 31,
|
(Unaudited, Dollars in Thousands)
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
Operating income (loss) by segment:
|
|
|
|
|
|
|
|
|
|
|
|
|
Radiation Measurement
|
|
$
|
9,969
|
|
$
|
9,414
|
|
$
|
18,867
|
|
$
|
18,798
|
Medical Physics
|
|
|
918
|
|
|
321
|
|
|
1,696
|
|
|
939
|
Medical Products
|
|
|
432
|
|
|
244
|
|
|
922
|
|
|
578
|
Corporate
|
|
|
(4,102)
|
|
|
(4,349)
|
|
|
(8,016)
|
|
|
(8,544)
|
Consolidated operating income
|
|
$
|
7,217
|
|
$
|
5,630
|
|
$
|
13,469
|
|
$
|
11,771
|
|
|
|
|
|
|
|
(Dollars in Thousands)
|
|
March 31,
2016
|
|
September 30,
2015
|
Segment assets:
|
|
|
|
|
|
|
Radiation Measurement
|
|
$
|
138,156
|
|
$
|
142,850
|
Medical Physics
|
|
|
45,094
|
|
|
43,677
|
Medical Products
|
|
|
47,770
|
|
|
48,308
|
Eliminations
|
|
|
(28,418)
|
|
|
(26,091)
|
Consolidated assets
|
|
$
|
202,602
|
|
$
|
208,744
|
(10)
Related Party Transactions
The Company has a minority interest in Yamasato, Fujiwara, Higa & Associates, Inc. doing business as Aquila. The Company provides dosimetry parts to Aqu
ila for its military contract
.
The Company also has a
50%
equity interest in
Nagase-Landauer, Ltd. (“Nagase”), a radiation measurement company in Japan.
The sales to and purchases from Aquila were as follows
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31,
|
|
Six Months Ended
March 31,
|
(Dollars in Thousands)
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
Sales to Aquila
|
|
$
|
18
|
|
$
|
1,870
|
|
$
|
414
|
|
$
|
3,673
|
Purchases from Aquila
|
|
|
214
|
|
|
23
|
|
|
204
|
|
|
31
|
Balance sheet items
associated with Aquila
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in Thousands)
|
|
March 31,
2016
|
|
September 30,
2015
|
Amounts in accounts receivable
|
|
$
|
1,919
|
|
$
|
2,795
|
Amounts in accounts payable
|
|
|
173
|
|
|
284
|
The sales to and purchases from Nagase were as
follows
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31,
|
|
Six Months Ended
March 31,
|
(Dollars in Thousands)
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
Sales to Nagase
|
|
$
|
1,196
|
|
$
|
109
|
|
$
|
2,294
|
|
$
|
755
|
Purchases from Nagase
|
|
|
99
|
|
|
196
|
|
|
694
|
|
|
462
|
Balance sheet items
associated with Nagase
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in Thousands)
|
|
March 31,
2016
|
|
September 30,
2015
|
Amounts in accounts receivable
|
|
$
|
819
|
|
$
|
769
|
Amounts in accounts payable
|
|
|
51
|
|
|
33
|
(11)
Subsequent Event
The Company divested its Medical Products business on May 3, 2016 for gross cash proceeds of $12 million. The assets of the Medical Products business represent approximately 4% of the Company’s consolidated assets, and the revenues of the Medical Products business represent approximately 7% of the Company’s consolidated revenues. The Company has evaluated whether this divestiture qualifies as a discontinued operation pursuant to FASB Accounting Standards Codification 205-20 “Discontinued Operations.” The Company has concluded that the
divestiture of the
Medical Products business
does not represent a strategic shift and is therefore not considered a discontinued operation, and is not material to be shown as assets held for sale as of March 31, 2016
.